Trials / Conditions / Squamous Cell Carcinoma of the Penis
Squamous Cell Carcinoma of the Penis
6 registered clinical trials studyying Squamous Cell Carcinoma of the Penis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as NCT06161532 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors NCT03517488 | Xencor, Inc. | Phase 1 |
| Unknown | PEN-866 in Patients With Advanced Solid Malignancies NCT03221400 | Tarveda Therapeutics | Phase 1 / Phase 2 |
| Withdrawn | Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE) NCT02014831 | Centre Leon Berard | Phase 2 |
| Completed | Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET] NCT02104063 | Queen Mary University of London | — |
| Terminated | Contemporary Characteristics of Penile Cancer NCT04996849 | M.D. Anderson Cancer Center | — |